WESPAC Advisors SoCal LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, Holdings Channel reports. The firm purchased 5,042 shares of the exchange traded fund’s stock, valued at approximately $615,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Capital A Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $26,000. Johnson Financial Group Inc. bought a new stake in SPDR S&P Biotech ETF during the second quarter worth about $31,000. Twin Peaks Wealth Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter worth about $32,000. Davis Capital Management acquired a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $40,000.
SPDR S&P Biotech ETF Stock Down 1.7%
NYSEARCA:XBI opened at $120.31 on Friday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $132.09. The firm has a market capitalization of $8.04 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The stock’s 50 day moving average price is $125.37 and its two-hundred day moving average price is $116.13.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
